Aptus Clinical
Aptus Clinical receives £150K for business expansion
Contract research organisation Aptus Clinical has received £150,000 from the Northern Powerhouse Investment Fund (NPIF) – FW Capital Debt Finance, to help it expand. more
Biopharma company enters partnership to support discovery and development of anti-cancer medicine
Artelo Biosciences, a biopharmaceutical company, has entered into a global research and development partnership with India-based integrated discovery-development service provider, Syngene, and UK-based specialist CRO, Aptus Clinical. more
Aptus Clinical to be one of 12 recipients of government funding
Contract CRO, Aptus Clinical, is to be one of 12 partners to receive government funding that will be used to ensure more patients benefit from a new generation of disease-fighting medicines for cancer and non-cancer illnesses more
Northern Powerhouse promotes North of England life sciences across the globe
A delegation from the North of England is heading to the BIO International Convention (BIO) in San Francisco this week – the first time the region’s life science sector has worked together to promote its offer on the global stage more
